A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations

 

 Buy Article Permissions and Reprints

ABSTRACT

Within vascular anomalies, vascular malformations are those present at birth that grow with the patient and exhibit abnormal dilated vascular channels lined by mature endothelium. Vascular tumors, the other group of vascular anomalies, demonstrate endothelial hypercellularity. Vascular malformations are further divided into low-flow varieties (capillary, venous, and lymphatic malformations) and high-flow varieties (arteriovenous malformation and fistula). All malformations exhibit a predictable group of clinical patterns that vary in severity and rate of progression. The interventional radiologist must incorporate this clinical data with characteristic ultrasound and magnetic resonance findings to arrive at a diagnosis. One must then decide in a multidisciplinary fashion, based on objective clinical criteria and image-based morphology, if the patent is a candidate for intervention. Sclerotherapy is a technique used to treat vascular malformations whereby an endothelial-cidal agent is introduced into the endoluminal compartment to initiate vascular closure. The high flow rate of an arteriovenous malformation requires the incorporation of superselective transarterial, direct, and transvenous access with flow reduction techniques to deliver adequate dose of sclerosant and embolic to the nidus. Satisfactory outcomes are seen in over half of all malformations patients. Similar treatment-related complications are seen between malformations but are lowest in lymphatic and highest in arteriovenous malformations.

REFERENCES

• 1 Lee B B, Bergan J J. Advanced management of congenital vascular malformations: a multidisciplinary approach.  Cardiovasc Surg. 2002;  10 523-533
  CrossrefPubMedGoogle Scholar
• 2 Legiehn G M, Heran M K. Venous malformations: classification, development, diagnosis, and interventional radiologic management.  Radiol Clin North Am. 2008;  46 545-597 , vi
  CrossrefPubMedGoogle Scholar
• 3 Nagy M, Brodsky L. Multidisciplinary approach to management of hemangiomas and vascular malformations.  Facial Plast Surg Clin North Am. 2001;  9 551-559
  PubMedGoogle Scholar
• 4 Lee B B. New approaches to the treatment of congenital vascular malformations (CVMs)—a single centre experience.  Eur J Vasc Endovasc Surg. 2005;  30 184-197
  CrossrefPubMedGoogle Scholar
• 5 Donnelly L F, Adams D M, Bisset III G S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic.  AJR Am J Roentgenol. 2000;  174 597-608
  CrossrefPubMedGoogle Scholar
• 6 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.  Plast Reconstr Surg. 1982;  69 412-422
  CrossrefPubMedGoogle Scholar
• 7 Mulliken J B, Zetter B R, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations.  Surgery. 1982;  92 348-353
  PubMedGoogle Scholar
• 8 Jackson I T, Carreño R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment.  Plast Reconstr Surg. 1993;  91 1216-1230
  CrossrefPubMedGoogle Scholar
• 9 Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood.  Pediatr Clin North Am. 1993;  40 1177-1200
  PubMedGoogle Scholar
• 10 Kilpatrick S E. Diagnostic Musculoskeletal Surgical Pathology: Clinicoradiologic and Cytologic Correlations. Philadelphia; Saunders 2004
  PubMedGoogle Scholar
• 11 North P E, Mihm Jr M C. Histopathological diagnosis of infantile hemangiomas and vascular malformations.  Facial Plast Surg Clin North Am. 2001;  9 505-524
  PubMedGoogle Scholar
• 12 Hein K D, Mulliken J B, Kozakewich H P, Upton J, Burrows P E. Venous malformations of skeletal muscle.  Plast Reconstr Surg. 2002;  110 1625-1635
  CrossrefPubMedGoogle Scholar
• 13 Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome.  Clin Lab Haematol. 2002;  24 243-251
  CrossrefPubMedGoogle Scholar
• 14 Dompmartin A, Acher A, Thibon P et al.. Association of localized intravascular coagulopathy with venous malformations.  Arch Dermatol. 2008;  144 873-877
  CrossrefPubMedGoogle Scholar
• 15 Clearkin K P, Enzinger F M. Intravascular papillary endothelial hyperplasia.  Arch Pathol Lab Med. 1976;  100 441-444
  PubMedGoogle Scholar
• 16 Legiehn G M, Heran M K. Classification, diagnosis, and interventional radiologic management of vascular malformations.  Orthop Clin North Am. 2006;  37 435-474 vii-viii
  CrossrefPubMedGoogle Scholar
• 17 Boyd J B, Mulliken J B, Kaban L B, Upton III J, Murray J E. Skeletal changes associated with vascular malformations.  Plast Reconstr Surg. 1984;  74 789-797
  CrossrefPubMedGoogle Scholar
• 18 Savader S J, Savader B L, Otero R R. Intraosseous arteriovenous malformations mimicking malignant disease.  Acta Radiol. 1988;  29 109-114
  PubMedGoogle Scholar
• 19 Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases.  J Am Acad Dermatol. 1997;  36(2 Pt 1) 219-225
  CrossrefPubMedGoogle Scholar
• 20 Garzon M C, Huang J T, Enjolras O, Frieden I J. Vascular malformations: Part I.  J Am Acad Dermatol. 2007;  56 353-370 quiz 371-374
  CrossrefPubMedGoogle Scholar
• 21 Dubois J, Soulez G, Oliva V L, Berthiaume M J, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues.  Radiographics. 2001;  21 1519-1531
  PubMedGoogle Scholar
• 22 Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group.  Pediatr Radiol. 1999;  29 879-893
  CrossrefPubMedGoogle Scholar
• 23 Nicolaides A N, Breddin H K, Carpenter P European Genetics Foundation et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.  Int Angiol. 2005;  24 1-26
  PubMedGoogle Scholar
• 24 Abernethy L J. Classification and imaging of vascular malformations in children.  Eur Radiol. 2003;  13 2483-2497
  CrossrefPubMedGoogle Scholar
• 25 Alqahtani A, Nguyen L T, Flageole H, Shaw K, Laberge J M. 25 years' experience with lymphangiomas in children.  J Pediatr Surg. 1999;  34 1164-1168
  CrossrefPubMedGoogle Scholar
• 26 Emery P J, Bailey C M, Evans J N. Cystic hygroma of the head and neck. A review of 37 cases.  J Laryngol Otol. 1984;  98 613-619
  CrossrefPubMedGoogle Scholar
• 27 Buckmiller L M. Update on hemangiomas and vascular malformations.  Curr Opin Otolaryngol Head Neck Surg. 2004;  12 476-487
  CrossrefPubMedGoogle Scholar
• 28 Frieden I, Enjolras O, Esterly N. Vascular birthmarks, other abnormalities of blood vessels and lymphatics. In: Schachner LA, Hansen RC Pediatric Dermatology. 3rd ed. New York; Mosby 2003
  PubMedGoogle Scholar
• 29 Kohout M P, Hansen M, Pribaz J J, Mulliken J B. Arteriovenous malformations of the head and neck: natural history and management.  Plast Reconstr Surg. 1998;  102 643-654
  CrossrefPubMedGoogle Scholar
• 30 Paltiel H J, Burrows P E, Kozakewich H P, Zurakowski D, Mulliken J B. Soft-tissue vascular anomalies: utility of US for diagnosis.  Radiology. 2000;  214 747-754
  PubMedGoogle Scholar
• 31 Trop I, Dubois J, Guibaud L et al.. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US.  Radiology. 1999;  212 841-845
  CrossrefPubMedGoogle Scholar
• 32 Sintzoff Jr S A, Gillard I, Van Gansbeke D, Gevenois P A, Salmon I, Struyven J. Ultrasound evaluation of soft tissue tumors.  J Belge Radiol. 1992;  75 276-280
  PubMedGoogle Scholar
• 33 Konez O, Burrows P E. Magnetic resonance of vascular anomalies.  Magn Reson Imaging Clin N Am. 2002;  10 363-388 vii
  CrossrefPubMedGoogle Scholar
• 34 Redondo P. [Vascular malformations (II). Diagnosis, pathology and treatment].  Actas Dermosifiliogr. 2007;  98 219-235
  CrossrefPubMedGoogle Scholar
• 35 Moukaddam H, Pollak J, Haims A H. MRI characteristics and classification of peripheral vascular malformations and tumors.  Skeletal Radiol. 2009;  38 535-547
  CrossrefPubMedGoogle Scholar
• 36 Fayad L M, Fayad L, Hazirolan T, Bluemke D, Mitchell S. Vascular malformations in the extremities: emphasis on MR imaging features that guide treatment options.  Skeletal Radiol. 2006;  35 127-137
  CrossrefPubMedGoogle Scholar
• 37 Meyer J S, Hoffer F A, Barnes P D, Mulliken J B. Biological classification of soft-tissue vascular anomalies: MR correlation.  AJR Am J Roentgenol. 1991;  157 559-564
  CrossrefPubMedGoogle Scholar
• 38 Vilanova J C, Barceló J, Smirniotopoulos J G et al.. Hemangioma from head to toe: MR imaging with pathologic correlation.  Radiographics. 2004;  24 367-385
  CrossrefPubMedGoogle Scholar
• 39 Ohgiya Y, Hashimoto T, Gokan T et al.. Dynamic MRI for distinguishing high-flow from low-flow peripheral vascular malformations.  AJR Am J Roentgenol. 2005;  185 1131-1137
  CrossrefPubMedGoogle Scholar
• 40 van Rijswijk C S, van der Linden E, van der Woude H J, van Baalen J M, Bloem J L. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations.  AJR Am J Roentgenol. 2002;  178 1181-1187
  CrossrefPubMedGoogle Scholar
• 41 Kern S, Niemeyer C, Darge K, Merz C, Laubenberger J, Uhl M. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations.  Acta Radiol. 2000;  41 453-457
  CrossrefPubMedGoogle Scholar
• 42 Rak K M, Yakes W F, Ray R L et al.. MR imaging of symptomatic peripheral vascular malformations.  AJR Am J Roentgenol. 1992;  159 107-112
  PubMedGoogle Scholar
• 43 Dobson M J, Hartley R W, Ashleigh R, Watson Y, Hawnaur J M. MR angiography and MR imaging of symptomatic vascular malformations.  Clin Radiol. 1997;  52 595-602
  CrossrefPubMedGoogle Scholar
• 44 Gulati M S, Paul S B, Batra A, Sarma D, Dadhwal V, Nath J. Uterine arteriovenous malformations: the role of intravenous “dual-phase” CT angiography.  Clin Imaging. 2000;  24 10-14
  CrossrefPubMedGoogle Scholar
• 45 Villavicencio J L. Primum non nocere: is it always true? The use of absolute ethanol in the management of congenital vascular malformations.  J Vasc Surg. 2001;  33 904-906
  CrossrefPubMedGoogle Scholar
• 46 Rautio R, Saarinen J, Laranne J, Salenius J P, Keski-Nisula L. Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment.  Acta Radiol. 2004;  45 397-403
  CrossrefPubMedGoogle Scholar
• 47 Rinker B, Karp N S, Margiotta M, Blei F, Rosen R, Rofsky N M. The role of magnetic resonance imaging in the management of vascular malformations of the trunk and extremities.  Plast Reconstr Surg. 2003;  112 504-510
  CrossrefPubMedGoogle Scholar
• 48 Do Y S, Yakes W F, Shin S W et al.. Ethanol embolization of arteriovenous malformations: interim results.  Radiology. 2005;  235 674-682
  CrossrefPubMedGoogle Scholar
• 49 Yakes W F, Rossi P, Odink H. How I do it. Arteriovenous malformation management.  Cardiovasc Intervent Radiol. 1996;  19 65-71
  CrossrefPubMedGoogle Scholar
• 50 Dubois J M, Sebag G H, De Prost Y, Teillac D, Chretien B, Brunelle F O. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc.  Radiology. 1991;  180 195-198
  PubMedGoogle Scholar
• 51 Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy.  Pediatr Radiol. 2003;  33 99-103
  CrossrefPubMedGoogle Scholar
• 52 Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy.  Eur J Radiol. 2005;  53 35-45
  CrossrefPubMedGoogle Scholar
• 53 Cabrera J, Cabrera Jr J J, Garcia-Olmedo M A, Redondo P. Treatment of venous malformations with sclerosant in microfoam form.  Arch Dermatol. 2003;  139 1409-1416
  CrossrefPubMedGoogle Scholar
• 54 Mimura H, Kanazawa S, Yasui K et al.. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.  Acta Med Okayama. 2003;  57 227-234
  PubMedGoogle Scholar
• 55 Tan K T, Kirby J, Rajan D K, Hayeems E, Beecroft J R, Simons M E. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2007;  18 343-351
  CrossrefPubMedGoogle Scholar
• 56 de Lorimier A A. Sclerotherapy for venous malformations.  J Pediatr Surg. 1995;  30 188-193 discussion 194
  CrossrefPubMedGoogle Scholar
• 57 Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues.  Radiographics. 2005;  25(25 Suppl 1) S159-S171
  CrossrefPubMedGoogle Scholar
• 58 O'Donovan J C, Donaldson J S, Morello F P, Pensler J M, Vogelzang R L, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.  AJR Am J Roentgenol. 1997;  169 723-729
  CrossrefPubMedGoogle Scholar
• 59 Pascarella L, Bergan J J, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam.  Ann Vasc Surg. 2005;  19 457-464
  CrossrefPubMedGoogle Scholar
• 60 Donnelly L F, Bisset III G S, Adams D M. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.  Pediatr Radiol. 2000;  30 415-419
  CrossrefPubMedGoogle Scholar
• 61 Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations.  Dermatol Surg. 2000;  26 323-328
  CrossrefPubMedGoogle Scholar
• 62 Shin B S, Do Y S, Lee B B et al.. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure.  Radiology. 2005;  235 1072-1077
  CrossrefPubMedGoogle Scholar
• 63 Yakes W F, Haas D K, Parker S H et al.. Symptomatic vascular malformations: ethanol embolotherapy.  Radiology. 1989;  170(3 Pt 2) 1059-1066
  CrossrefPubMedGoogle Scholar
• 64 Yakes W F, Krauth L, Ecklund J et al.. Ethanol endovascular management of brain arteriovenous malformations: initial results.  Neurosurgery. 1997;  40 1145-1152 discussion 1152-1154
  CrossrefPubMedGoogle Scholar
• 65 Choi Y H, Han M H, O-Ki K, Cha S H, Chang K H. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.  J Vasc Interv Radiol. 2002;  13 475-482
  CrossrefPubMedGoogle Scholar
• 66 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity.  Anesth Analg. 1995;  80 415-417
  CrossrefPubMedGoogle Scholar
• 67 Garel L, Mareschal J L, Gagnadoux M F, Pariente D, Guilbert M, Sauvegrain J. Fatal outcome after ethanol renal ablation in child with end-stage kidneys.  AJR Am J Roentgenol. 1986;  146 593-594
  PubMedGoogle Scholar
• 68 Mason K P, Michna E, Zurakowski D, Koka B V, Burrows P E. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies.  Radiology. 2000;  217 127-132
  PubMedGoogle Scholar
• 69 Stefanutto T B, Halbach V. Bronchospasm precipitated by ethanol injection in arteriovenous malformation.  AJNR Am J Neuroradiol. 2003;  24 2050-2051
  PubMedGoogle Scholar
• 70 Yakes W F, Baker R. Cardiopulmonary collapse: a sequelae of ethanol embolotherapy. Paper presented at: 79th Scientific Assembly and Annual Meeting of the Radiological Society of North America 1993 Chicago, IL;
  PubMedGoogle Scholar
• 71 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol).  Scand J Plast Reconstr Surg Hand Surg. 1997;  31 145-150
  CrossrefPubMedGoogle Scholar
• 72 Guex J J. Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler).  J Dermatol Surg Oncol. 1993;  19 959-961
  PubMedGoogle Scholar
• 73 Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.  J Clin Ultrasound. 2002;  30 416-423
  CrossrefPubMedGoogle Scholar
• 74 Cacciola E, Giustolisi R, Musso R et al.. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.  J Lab Clin Med. 1987;  109 225-226
  PubMedGoogle Scholar
• 75 Marrocco-Trischitta M M, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.  Dermatol Surg. 2002;  28 153-155
  CrossrefPubMedGoogle Scholar
• 76 Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome.  Isr Med Assoc J. 2007;  9 72-75
  PubMedGoogle Scholar
• 77 Suzuki N, Nakao A, Nonami T, Takagi H. Experimental study on the effects of sclerosants for esophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics.  Gastroenterol Jpn. 1992;  27 309-316
  PubMedGoogle Scholar
• 78 Liu Y, Liu D, Wang Y, Zhang W, Zhao F. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.  J Oral Maxillofac Surg. 2009;  67 98-104
  PubMedGoogle Scholar
• 79 Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu G O. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.  Pediatr Surg Int. 2004;  19 766-773
  CrossrefPubMedGoogle Scholar
• 80 Yang Y, Sun M, Hou R et al.. Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.  J Oral Maxillofac Surg. 2008;  66 2219-2225
  CrossrefPubMedGoogle Scholar
• 81 Zhi K, Wen Y, Li L, Ren W. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region.  Int J Pediatr Otorhinolaryngol. 2008;  72 593-597
  CrossrefPubMedGoogle Scholar
• 82 Chen W L, Yang Z H, Bai Z B, Wang Y Y, Huang Z Q, Wang Y J. A pilot study on combination compartmentalisation and sclerotherapy for the treatment of massive venous malformations of the face and neck.  J Plast Reconstr Aesthet Surg. 2008;  61 1486-1492
  CrossrefPubMedGoogle Scholar
• 83 Mathur N N, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.  Int J Pediatr Otorhinolaryngol. 2005;  69 75-80
  CrossrefPubMedGoogle Scholar
• 84 Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.  J Vasc Surg. 2008;  47 1292-1299
  CrossrefPubMedGoogle Scholar
• 85 Sung M W, Chang S O, Choi J H, Kim J Y. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck.  Am J Otolaryngol. 1995;  16 236-241
  CrossrefPubMedGoogle Scholar
• 86 Bechard D E, Fairman R P, DeBlois G G, Via C T. Fatal pulmonary fibrosis from low-dose bleomycin therapy.  South Med J. 1987;  80 646-649
  CrossrefPubMedGoogle Scholar
• 87 Okada A, Kubota A, Fukuzawa M, Imura K, Kamata S. Injection of bleomycin as a primary therapy of cystic lymphangioma.  J Pediatr Surg. 1992;  27 440-443
  CrossrefPubMedGoogle Scholar
• 88 Gabal A M. Percutaneous technique for sclerotherapy of vertebral hemangioma compressing spinal cord.  Cardiovasc Intervent Radiol. 2002;  25 494-500
  CrossrefPubMedGoogle Scholar
• 89 Johann A C, Aguiar M C, do Carmo M A, Gomez R S, Castro W H, Mesquita R A. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;  100 579-584
  CrossrefPubMedGoogle Scholar
• 90 Lewin J S, Merkle E M, Duerk J L, Tarr R W. Low-flow vascular malformations in the head and neck: safety and feasibility of MR imaging-guided percutaneous sclerotherapy—preliminary experience with 14 procedures in three patients.  Radiology. 1999;  211 566-570
  PubMedGoogle Scholar
• 91 Górriz E, Carreira J M, Reyes R et al.. Intramuscular low flow vascular malformations: treatment by means of direct percutaneous embolization.  Eur J Radiol. 1998;  27 161-165
  CrossrefPubMedGoogle Scholar
• 92 Kühne D, Helmke K. Embolization with “Ethibloc” of vascular tumors and arteriovenous malformations in the head and neck.  Neuroradiology. 1982;  23 253-258
  CrossrefPubMedGoogle Scholar
• 93 Riche M C, Hadjean E, Tran-Ba-Huy P, Merland J J. The treatment of capillary-venous malformations using a new fibrosing agent.  Plast Reconstr Surg. 1983;  71 607-614
  CrossrefPubMedGoogle Scholar
• 94 Deveikis J P. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck.  Arch Facial Plast Surg. 2005;  7 322-325
  CrossrefPubMedGoogle Scholar
• 95 Suh J S, Shin K H, Na J B, Won J Y, Hahn S B. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol.  Cardiovasc Intervent Radiol. 1997;  20 268-273
  CrossrefPubMedGoogle Scholar
• 96 Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications.  AJR Am J Roentgenol. 2003;  180 1399-1401
  CrossrefPubMedGoogle Scholar
• 97 Cabrera Garrido J R, Cabrera Garcia-Olmedo J R, Garcia-Olmedo Dominquez M A. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants.  Phlebologie. 1997;  50 351-353
  PubMedGoogle Scholar
• 98 Tessari L. Nouvelle technique d'obtention de la sclero-mousse.  Phlebologie. 2000;  53 129
  PubMedGoogle Scholar
• 99 Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.  Dermatol Surg. 2002;  28 11-15
  CrossrefPubMedGoogle Scholar
• 100 Hamel-Desnos C, Desnos P, Wollmann J C, Ouvry P, Mako S, Allaert F A. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.  Dermatol Surg. 2003;  29 1170-1175 discussion 1175
  CrossrefPubMedGoogle Scholar
• 101 Boll D T, Merkle E M, Lewin J S. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome.  Radiology. 2004;  233 376-384
  CrossrefPubMedGoogle Scholar
• 102 Hayashi N, Masumoto T, Okubo T et al.. Hemangiomas in the face and extremities: MR-guided sclerotherapy—optimization with monitoring of signal intensity changes in vivo.  Radiology. 2003;  226 567-572
  CrossrefPubMedGoogle Scholar
• 103 Lee C H, Chen S G. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.  Br J Plast Surg. 2005;  58 1073-1078
  CrossrefPubMedGoogle Scholar
• 104 Woods J E. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions.  Plast Reconstr Surg. 1987;  79 542-549
  CrossrefPubMedGoogle Scholar
• 105 Bai Y, Jia J, Huang X X, Alsharif M J, Zhao J H, Zhao Y F. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.  J Oral Maxillofac Surg. 2009;  67 251-256
  CrossrefPubMedGoogle Scholar
• 106 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.  Radiology. 1997;  204 651-654
  CrossrefPubMedGoogle Scholar
• 107 Giguère C M, Bauman N M, Sato Y et al.. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.  Arch Otolaryngol Head Neck Surg. 2002;  128 1137-1144
  CrossrefPubMedGoogle Scholar
• 108 Goyal M, Mishra N K, Sharma A, Gaikwad S B, Mohanty B K, Sharma A. Alcohol ablation of symptomatic vertebral hemangiomas.  AJNR Am J Neuroradiol. 1999;  20 1091-1096
  PubMedGoogle Scholar
• 109 Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children.  Eur Arch Otorhinolaryngol. 2002;  259 274-278
  CrossrefPubMedGoogle Scholar
• 110 Herbreteau D, Riche M C, Enjolras O et al.. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients.  Int Angiol. 1993;  12 34-39
  PubMedGoogle Scholar
• 111 Molitch H I, Unger E C, Witte C L, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas.  Radiology. 1995;  194 343-347
  CrossrefPubMedGoogle Scholar
• 112 Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Picibanil).  Cardiovasc Intervent Radiol. 2003;  26 31-36
  CrossrefPubMedGoogle Scholar
• 113 Shankar K R, Roche C J, Carty H M, Turnock R R. Cystic retroperitoneal lymphangioma: treatment by image-guided percutaneous catheter drainage and sclerotherapy.  Eur Radiol. 2001;  11 1021-1023
  CrossrefPubMedGoogle Scholar
• 114 Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children.  Br J Surg. 1987;  74 690-691
  CrossrefPubMedGoogle Scholar
• 115 Sung M W, Lee D W, Kim D Y et al.. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.  Laryngoscope. 2001;  111 1430-1433
  CrossrefPubMedGoogle Scholar
• 116 Uchida K, Inoue M, Araki T, Miki C, Kusunoki M. Huge scrotal, flank, and retroperitoneal lymphangioma successfully treated by OK-432 sclerotherapy.  Urology. 2002;  60 1112
  PubMedGoogle Scholar
• 117 Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M. Sclerosing treatment of lymphangiomas with OK-432.  Arch Dis Child. 2000;  82 316-318
  CrossrefPubMedGoogle Scholar
• 118 Greinwald Jr J H, Burke D K, Sato Y et al.. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.  Otolaryngol Head Neck Surg. 1999;  121 381-387
  CrossrefPubMedGoogle Scholar
• 119 Smith R J, Burke D K, Sato Y, Poust R I, Kimura K, Bauman N M. OK-432 therapy for lymphangiomas.  Arch Otolaryngol Head Neck Surg. 1996;  122 1195-1199
  CrossrefPubMedGoogle Scholar
• 120 Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432.  J Pediatr Surg. 1995;  30 1159-1160
  CrossrefPubMedGoogle Scholar
• 121 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma.  J Pediatr Surg. 1994;  29 784-785
  CrossrefPubMedGoogle Scholar
• 122 Duman L, Karnak I, Akinci D, Tanyel F C. Extensive cervical-mediastinal cystic lymphatic malformation treated with sclerotherapy in a child with Klippel-Trenaunay syndrome.  J Pediatr Surg. 2006;  41 e21-e24
  PubMedGoogle Scholar
• 123 Baskin D, Tander B, Bankaoğlu M. Local bleomycin injection in the treatment of lymphangioma.  Eur J Pediatr Surg. 2005;  15 383-386
  Article in Thieme ConnectPubMedGoogle Scholar
• 124 Mabeta P, Ionescu G O, Muir T et al.. Bleomycin levels in patients undergoing intralesional bleomycin treatment for lymphatic malformation. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies 2004 Wellington, New Zealand;
  PubMedGoogle Scholar
• 125 Zhong P Q, Zhi F X, Li R, Xue J L, Shu G Y. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;  86 139-144
  CrossrefPubMedGoogle Scholar
• 126 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma.  J Pediatr Surg. 1995;  30 1282-1287
  CrossrefPubMedGoogle Scholar
• 127 Tanaka K, Inomata Y, Utsunomiya H et al.. Sclerosing therapy with bleomycin emulsion for lymphangioma in children.  Pediatr Surg Int. 1990;  5 270-273
  PubMedGoogle Scholar
• 128 Tanigawa N, Shimomatsuya T, Takahashi K et al.. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion.  Cancer. 1987;  60 741-749
  CrossrefPubMedGoogle Scholar
• 129 Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleomycin treatment for cystic hygroma in children.  Nippon Geka Hokan. 1977;  46 607-614
  PubMedGoogle Scholar
• 130 Cordes B M, Seidel F G, Sulek M, Giannoni C M, Friedman E M. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations.  Otolaryngol Head Neck Surg. 2007;  137 962-964
  CrossrefPubMedGoogle Scholar
• 131 Shiels II W E, Kenney B D, Caniano D A, Besner G E. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.  J Pediatr Surg. 2008;  43 136-139 discussion 140
  CrossrefPubMedGoogle Scholar
• 132 Wible B C, Mitchell S. Doxycycline sclerotherapy of an intraosseous femoral lymphatic malformation: case report and literature review.  J Vasc Interv Radiol. 2009;  20 660-663
  CrossrefPubMedGoogle Scholar
• 133 Cho S K, Do Y S, Kim D I et al.. Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization.  Korean J Radiol. 2008;  9 258-267
  CrossrefPubMedGoogle Scholar
• 134 Do Y S, Park K B, Cho S K. How do we treat arteriovenous malformations (tips and tricks)?.  Tech Vasc Interv Radiol. 2007;  10 291-298
  CrossrefPubMedGoogle Scholar
• 135 Houdart E, Gobin Y P, Casasco A, Aymard A, Herbreteau D, Merland J J. A proposed angiographic classification of intracranial arteriovenous fistulae and malformations.  Neuroradiology. 1993;  35 381-385
  CrossrefPubMedGoogle Scholar
• 136 Lee B B, Do Y S, Yakes W, Kim D I, Mattassi R, Hyon W S. Management of arteriovenous malformations: a multidisciplinary approach.  J Vasc Surg. 2004;  39 590-600
  CrossrefPubMedGoogle Scholar
• 137 Jackson J E, Mansfield A O, Allison D J. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques.  Cardiovasc Intervent Radiol. 1996;  19 323-328
  CrossrefPubMedGoogle Scholar
• 138 Rao V R, Mandalam K R, Gupta A K, Kumar S, Joseph S. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.  AJNR Am J Neuroradiol. 1989;  10 135-141
  PubMedGoogle Scholar
• 139 Tan K T, Simons M E, Rajan D K, Terbrugge K. Peripheral high-flow arteriovenous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2004;  15 1071-1080
  PubMedGoogle Scholar
• 140 White Jr R I, Pollak J, Persing J, Henderson K J, Thomson J G, Burdge C M. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations.  J Vasc Interv Radiol. 2000;  11 1285-1295
  CrossrefPubMedGoogle Scholar
• 141 Weber J. Techniques and results of therapeutic catheter embolization of congenital vascular defects.  Int Angiol. 1990;  9 214-223
  PubMedGoogle Scholar
• 142 Bae S, Do Y S, Shin S W et al.. Ethanol embolotherapy of pelvic arteriovenous malformations: an initial experience.  Korean J Radiol. 2008;  9 148-154
  CrossrefPubMedGoogle Scholar
• 143 Mitsuzaki K, Yamashita Y, Utsunomiya D et al.. Balloon-occluded retrograde transvenous embolization of a pelvic arteriovenous malformation.  Cardiovasc Intervent Radiol. 1999;  22 518-520
  CrossrefPubMedGoogle Scholar
• 144 Doppman J L, Pevsner P H. Embolization of arteriovenous malformations by direct percutaneous puncture.  AJR Am J Roentgenol. 1983;  140 773-778
  PubMedGoogle Scholar
• 145 Gomes A S. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches.  Radiology. 1994;  190 191-198
  PubMedGoogle Scholar
• 146 Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy.  Cardiovasc Intervent Radiol. 2001;  24 348-351
  CrossrefPubMedGoogle Scholar
• 147 Pollak J S, White Jr R I. The use of cyanoacrylate adhesives in peripheral embolization.  J Vasc Interv Radiol. 2001;  12 907-913
  CrossrefPubMedGoogle Scholar
• 148 Castaneda F, Goodwin S C, Swischuk J L et al.. Treatment of pelvic arteriovenous malformations with ethylene vinyl alcohol copolymer (Onyx).  J Vasc Interv Radiol. 2002;  13 513-516
  CrossrefPubMedGoogle Scholar
• 149 Numan F, Omeroglu A, Kara B, Cantaşdemir M, Adaletli I, Kantarci F. Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer (Onyx).  J Vasc Interv Radiol. 2004;  15 939-946
  CrossrefPubMedGoogle Scholar
• 150 Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H. A new liquid material for embolization of arteriovenous malformations.  AJNR Am J Neuroradiol. 1990;  11 163-168
  PubMedGoogle Scholar
• 151 Fayad L M, Hazirolan T, Carrino J A, Bluemke D A, Mitchell S. Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures.  Skeletal Radiol. 2008;  37 895-901
  CrossrefPubMedGoogle Scholar
• 152 Lee B B, Do Y S, Byun H S, Choo I W, Kim D I, Huh S H. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.  J Vasc Surg. 2003;  37 533-538
  CrossrefPubMedGoogle Scholar
• 153 Goyal M, Causer P A, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.  Radiology. 2002;  223 639-644
  CrossrefPubMedGoogle Scholar
• 154 Lee B B, Kim D I, Huh S et al.. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.  J Vasc Surg. 2001;  33 764-772
  CrossrefPubMedGoogle Scholar
• 155 Coetzee P F, Ionescu G O, Fourie P et al.. Results of intralesional bleomycin injection treatment for congenital vascular anomalies. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies 2004 Wellington, New Zealand;
  PubMedGoogle Scholar
• 156 Kim K H, Sung M W, Roh J L, Han M H. Sclerotherapy for congenital lesions in the head and neck.  Otolaryngol Head Neck Surg. 2004;  131 307-316
  CrossrefPubMedGoogle Scholar
• 157 Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleomycin treatment for cystic hygroma in children.  Nippon Geka Hokan. 1977;  46 607-614
  PubMedGoogle Scholar
• 158 van der Linden E, Pattynama P M, Heeres B C, de Jong S C, Hop W C, Kroft L J. Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations.  Radiology. 2009;  251 926-932
  CrossrefPubMedGoogle Scholar
• 159 Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations.  Dermatol Surg. 2000;  26 323-328
  CrossrefPubMedGoogle Scholar
• 160 Sanlialp I, Karnak I, Tanyel F C, Senocak M E, Büyükpamukçu N. Sclerotherapy for lymphangioma in children.  Int J Pediatr Otorhinolaryngol. 2003;  67 795-800
  CrossrefPubMedGoogle Scholar
• 161 Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations.  J Dermatol. 1997;  24 701-710
  PubMedGoogle Scholar
• 162 Vaidya S, Cooke D, Kogut M, Stratil P, Bittles M, Sidhu M. Imaging and percutaneous treatment of vascular anomalies.  Semin Intervent Radiol. 2008;  25 216-233
  Article in Thieme ConnectPubMedGoogle Scholar

Gerald M LegiehnM.D. F.R.C.P.C. 

Department of Radiology, Vancouver General Hospital

899 W. 12th Avenue, Vancouver, British Columbia, Canada V5Z 1M9

Email: gerald@telus.net